Evaluation of Combination Therapy (75 mg/day Naftopidil plus 30 mg/day Urapidil) in Patients with BPH/LUTS Poorly Responding to alpha1 Blocker Monotherapy

Matsuo T1, Miyata Y1, Watanabe S1, Sagara Y1, Ohba K1, Sakai H1

Abstract Category

Benign Prostatic Hyperplasia (BPH)

Abstract 641
Read by Title
Scientific Non Discussion Abstract Session 31
1. Department of Urology, Nagasaki University School of Medicine
Links

Abstract